Literature DB >> 11500371

Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics.

K J Cross1, S A Wharton, J J Skehel, D C Wiley, D A Steinhauer.   

Abstract

Influenza haemagglutinin (HA) is responsible for fusing viral and endosomal membranes during virus entry. In this process, conformational changes in the HA relocate the HA(2) N-terminal 'fusion peptide' to interact with the target membrane. The highly conserved HA fusion peptide shares composition and sequence features with functionally analogous regions of other viral fusion proteins, including the presence and distribution of glycines and large side-chain hydrophobic residues. HAs with mutations in the fusion peptide were expressed using vaccinia virus recombinants to examine the requirement for fusion of specific hydrophobic residues and the significance of glycine spacing. Mutant HAs were also incorporated into infectious influenza viruses for analysis of their effects on infectivity and replication. In most cases alanine, but not glycine substitutions for the large hydrophobic residues, yielded fusion-competent HAs and infectious viruses, suggesting that the conserved spacing of glycines may be structurally significant. When viruses containing alanine substitutions for large hydrophobic residues were passaged, pseudoreversion to valine was observed, indicating a preference for large hydrophobic residues at specific positions. Viruses were also obtained with serine, leucine or phenylalanine as the N-terminal residue, but these replicated to significantly lower levels than wild-type virus with glycine at this position.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11500371      PMCID: PMC125568          DOI: 10.1093/emboj/20.16.4432

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  62 in total

1.  The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion.

Authors:  G M Taylor; D A Sanders
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

2.  Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide.

Authors:  S G Lazarowitz; P W Choppin
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

3.  Activation of influenza A viruses by trypsin treatment.

Authors:  H D Klenk; R Rott; M Orlich; J Blödorn
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

4.  Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1977-07-01       Impact factor: 3.616

5.  Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation.

Authors:  M J Gething; J M White; M D Waterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

6.  Structural characterization of the human respiratory syncytial virus fusion protein core.

Authors:  X Zhao; M Singh; V N Malashkevich; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

7.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.

Authors:  I A Wilson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

8.  Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion.

Authors:  J J Skehel; P M Bayley; E B Brown; S R Martin; M D Waterfield; J M White; I A Wilson; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

9.  Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage.

Authors:  W Garten; F X Bosch; D Linder; R Rott; H D Klenk
Journal:  Virology       Date:  1981-12       Impact factor: 3.616

10.  Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion.

Authors:  R S Daniels; A R Douglas; J J Skehel; D C Wiley
Journal:  J Gen Virol       Date:  1983-08       Impact factor: 3.891

View more
  34 in total

1.  The influenza hemagglutinin fusion domain is an amphipathic helical hairpin that functions by inducing membrane curvature.

Authors:  Sean T Smrt; Adrian W Draney; Justin L Lorieau
Journal:  J Biol Chem       Date:  2014-11-14       Impact factor: 5.157

2.  The complete influenza hemagglutinin fusion domain adopts a tight helical hairpin arrangement at the lipid:water interface.

Authors:  Justin L Lorieau; John M Louis; Ad Bax
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-02       Impact factor: 11.205

3.  Activation of fusion by the SER virus F protein: a low-pH-dependent paramyxovirus entry process.

Authors:  Shaguna Seth; Annelet Vincent; R W Compans
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

4.  Structure-based analysis of the herpes simplex virus glycoprotein D binding site present on herpesvirus entry mediator HveA (HVEM).

Authors:  Sarah A Connolly; Daniel J Landsburg; Andrea Carfi; Don C Wiley; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Functional analysis of the putative fusion domain of the baculovirus envelope fusion protein F.

Authors:  Marcel Westenberg; Frank Veenman; Els C Roode; Rob W Goldbach; Just M Vlak; Douwe Zuidema
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Orientation and interaction of oblique cylindrical inclusions embedded in a lipid monolayer: a theoretical model for viral fusion peptides.

Authors:  Yonathan Kozlovsky; Joshua Zimmerberg; Michael M Kozlov
Journal:  Biophys J       Date:  2004-08       Impact factor: 4.033

Review 7.  The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement.

Authors:  F S Cohen; G B Melikyan
Journal:  J Membr Biol       Date:  2004-05-01       Impact factor: 1.843

8.  Fusogenic variants of a noncytopathic paramyxovirus.

Authors:  Shaguna Seth; Ioanna Skountzou; Kim M Gernert; Richard W Compans
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

9.  Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.

Authors:  Min Li; Zhu-Nan Li; Qizhi Yao; Chinglai Yang; David A Steinhauer; Richard W Compans
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

10.  Bilayer conformation of fusion peptide of influenza virus hemagglutinin: a molecular dynamics simulation study.

Authors:  Qiang Huang; Cheng-Lung Chen; Andreas Herrmann
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.